IncidenceSurvival RateCell SurvivalDisease-Free SurvivalSurvivalSurvival AnalysisGraft SurvivalRetrospective StudiesTreatment OutcomeTime FactorsFollow-Up StudiesRisk FactorsKaplan-Meier EstimateProspective StudiesProportional Hazards ModelsCohort StudiesNeoplasm StagingRegistriesPrognosisAntineoplastic Combined Chemotherapy ProtocolsMultivariate AnalysisCombined Modality TherapyApoptosisBreast NeoplasmsLung NeoplasmsInfant, NewbornNeoplasmsAge DistributionRisk AssessmentAdenocarcinomaNeoplasm Recurrence, LocalPostoperative ComplicationsUnited StatesRecurrenceAntineoplastic AgentsDisease ProgressionImmunohistochemistrySignal TransductionTumor Markers, BiologicalLiver NeoplasmsSex DistributionSEER ProgramNeoplasm MetastasisCell Line, TumorPredictive Value of TestsMice, Inbred C57BLColorectal NeoplasmsBrain NeoplasmsTransplantation, HomologousJapanCarcinoma, Squamous CellPrevalenceRiskPregnancyChemotherapy, AdjuvantDrug Administration SchedulePopulation SurveillanceCell ProliferationMutationLymphatic MetastasisGraft RejectionDisease Models, AnimalKidney TransplantationCells, CulturedDose-Response Relationship, DrugCisplatinStomach NeoplasmsCyclophosphamideSkin NeoplasmsMelanomaChi-Square DistributionRegression AnalysisLiver TransplantationSwedenFluorouracilActuarial AnalysisCarcinomaDoxorubicinSeasonsImmunosuppressive AgentsProstatic NeoplasmsSeverity of Illness IndexCarcinoma, Non-Small-Cell LungCarcinoma, HepatocellularAge FactorsAcute DiseaseLife TablesGene Expression Regulation, NeoplasticEsophageal NeoplasmsMice, KnockoutPancreatic NeoplasmsNeoplasm InvasivenessPoisson DistributionCause of DeathRandomized Controlled Trials as TopicAnalysis of VarianceCase-Control StudiesReoperationVincristineRemission Induction